Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Breakdown of the Company Revenue (Details)

v3.8.0.1
Balance Sheet Components - Breakdown of the Company Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Concentration Risk [Line Items]        
Revenues $ 69,030 $ 54,422 $ 185,651 $ 151,978
U.S. revenue        
Concentration Risk [Line Items]        
Revenues 51,844 39,470 142,123 113,963
Non-U.S. revenue        
Concentration Risk [Line Items]        
Revenues $ 17,186 $ 14,952 $ 43,528 $ 38,015